X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Prism Medico and Pharmacy Ltd.
BSE CODE: 512217   |   NSE CODE: NA   |   ISIN CODE : INE730E01016   |   15-Dec-2025 Hrs IST
BSE NSE
Rs. 19.03
0.88 ( 4.85% )
 
Prev Close ( Rs.)
18.15
Open ( Rs.)
18.95
 
High ( Rs.)
19.05
Low ( Rs.)
18.62
 
Volume
6160
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-0.08  -0.04  -0.13  -0.61  -0.21  
   CEPS(Rs)-0.07  -0.03  -0.11  -0.60  -0.19  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)24.89  24.97  25.01  20.71  21.32  
   Tax Rate(%)25.99  23.57  25.34  25.86  25.80  
Margin Ratios          
   Core EBITDA Margin(%)-12.09  -4.71  -7.63  -5.80  -0.97  
   EBIT Margin(%)-10.14  -0.71  -8.02  -5.90  -1.04  
   Pre Tax Margin(%)-10.41  -0.96  -8.04  -5.91  -1.05  
   PAT Margin (%)-7.71  -0.73  -6.00  -4.38  -0.78  
   Cash Profit Margin (%)-7.04  -0.55  -5.49  -4.28  -0.70  
Performance Ratios          
   ROA(%)-0.32  -0.14  -0.55  -2.18  -0.60  
   ROE(%)-0.32  -0.14  -0.55  -2.90  -1.00  
   ROCE(%)-0.42  -0.14  -0.74  -3.91  -1.35  
   Asset Turnover(x)0.04  0.19  0.09  0.50  0.78  
   Sales/Fixed Asset(x)20.09  80.81  30.17  63.64  76.22  
   Working Capital/Sales(x)0.04  0.20  0.09  0.69  1.54  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.05  0.01  0.03  0.02  0.01  
   Receivable days2100.76  527.23  1384.74  397.56  346.74  
   Inventory Days3910.85  844.82  1944.81  251.09  53.28  
   Payable days0  4.39  0  0  184.95  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-159.69  -1027.39  -249.06  -12.79  -60.06  
   Price/Book(x)0.47  1.09  1.14  0.37  0.55  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)11.14  5.63  13.59  0.54  0.42  
   EV/Core EBITDA(x)-117.54  -1054.96  -181.15  -9.32  -42.94  
   EV/EBIT(x)-109.84  -787.43  -169.42  -9.16  -39.89  
   EV/CE(x)0.47  1.09  1.14  0.36  0.54  
   M Cap / Sales11.25  5.65  13.66  0.55  0.42  
Growth Ratio          
   Net Sales Growth(%)-78.40  130.20  -84.95  -49.63  -37.66  
   Core EBITDA Growth(%)-283.97  83.63  80.54  -201.30  -223.51  
   EBIT Growth(%)-206.70  79.49  79.56  -184.90  -157.80  
   PAT Growth(%)-127.57  71.95  79.37  -184.50  -158.70  
   EPS Growth(%)-127.48  71.94  79.38  -184.51  -158.62  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)32.43  147.68  65.35  708.22  2.26  
   Quick Ratio(x)18.08  80.97  36.13  319.61  1.70  
   Interest Cover(x)-37.71  -2.94  -339.67  -1083.14  -709.78  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00